1-3 of 3
Karima Amaador
Close
Sort by
Journal Articles

Evaluating Patients' Preferences Regarding Treatment Options for Waldenström's Macroglobulinemia, a Discrete-Choice-Experiment

Karima Amaador, Pythia Nieuwkerk, Monique C. Minnema, Marie José Kersten, Josephine M.I. Vos
Journal: Blood
Blood (2021) 138 (Supplement 1): 835.
https://doi.org/10.1182/blood-2021-150154
Published: 2021
Journal Articles

Serum Neurofilament Light Chain and Contactin-1 Levels Are Not Potential Serum Biomarkers in Anti-MAG IgM Paraprotein Related Peripheral Neuropathy

Karima Amaador, Luuk Wieske, Marleen J.A. Koel-Simmelink, Charlotte E. Teunissen, Keon de Heer, Monique C. Minnema, Nicolette C. Notermans, Filip Eftimov, Marie José Kersten, Josephine M.I. Vos
Journal: Blood
Blood (2021) 138 (Supplement 1): 4733.
https://doi.org/10.1182/blood-2021-150295
Published: 2021
Journal Articles

Ixazomib, Rituximab and Dexamethasone (IRD) in Patients with Relapsed or Progressive Waldenstrom's Macroblobulinemia: Results of the Prospective Phase I/II HOVON 124/Ecwm-R2 Trial

Marie José Kersten, MD PhD, Monique C. Minnema, Josephine M. Vos, MD PhD, Kazem Nasserinejad, Marcel Kap, BSc, Eftathios Kastritis, Maria Gavriatopoulou, MD, Martine E.D. Chamuleau, Dries Deeren, MD PhD, Lidwine Winnifred Tick, MD PhD, Jeanette K. Doorduijn, MD PhD, Fritz Offner, MD, Lara H Bohmer, MD, Karima Amaador, MD, Roberto D Liu, BSc, Steven T Pals, MD PhD, Meletios A. Dimopoulos, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 344.
https://doi.org/10.1182/blood-2019-122365
Published: 2019